Strata Critical Medical (NASDAQ:SRTA) Short Interest Down 47.9% in June

Strata Critical Medical (NASDAQ:SRTA) was the recipient of a large decline in short interest in June. As of June 30th, there was short interest totaling 4,075,056 shares, a decline of 47.9% from the June 15th total of 7,824,961 shares. Currently, 5.6% of the company’s stock are sold short. Based on an average trading volume of 1,622,698 shares, the short-interest ratio is presently 2.5 days.

Insider Buying and Selling at Strata Critical Medical

In other news, CAO Amir Cohen sold 4,655 shares of Strata Critical Medical stock in a transaction that occurred on Monday, June 8th. The shares were sold at an average price of $5.87, for a total value of $27,324.85. Following the sale, the chief accounting officer directly owned 146,608 shares in the company, valued at $860,588.96. This trade represents a 3.08% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO William A. Heyburn sold 31,671 shares of the business’s stock in a transaction on Monday, June 8th. The stock was sold at an average price of $5.87, for a total transaction of $185,908.77. Following the completion of the sale, the chief executive officer directly owned 1,548,997 shares in the company, valued at approximately $9,092,612.39. This represents a 2.00% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders have sold 116,931 shares of company stock worth $687,184. Corporate insiders own 15.50% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the company. Allied Private Wealth LLC acquired a new position in Strata Critical Medical during the second quarter worth about $31,000. Bank of America Corp DE boosted its stake in shares of Strata Critical Medical by 16.2% in the 1st quarter. Bank of America Corp DE now owns 181,574 shares of the company’s stock valued at $759,000 after purchasing an additional 25,379 shares in the last quarter. Quantinno Capital Management LP grew its holdings in shares of Strata Critical Medical by 98.7% during the 1st quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock valued at $599,000 after purchasing an additional 71,155 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Strata Critical Medical by 11.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company’s stock valued at $6,759,000 after purchasing an additional 172,154 shares during the last quarter. Finally, Principal Financial Group Inc. bought a new stake in shares of Strata Critical Medical during the 1st quarter valued at approximately $537,000. 47.36% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. Craig Hallum started coverage on shares of Strata Critical Medical in a research report on Wednesday, March 25th. They set a “buy” rating and a $8.00 price target on the stock. B. Riley Financial assumed coverage on Strata Critical Medical in a report on Wednesday, March 25th. They issued a “buy” rating and a $8.00 price objective for the company. Zacks Research raised Strata Critical Medical to a “hold” rating in a research report on Thursday, March 26th. Finally, Weiss Ratings upgraded Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, May 11th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $8.00.

Strata Critical Medical Stock Performance

Strata Critical Medical stock traded down $0.19 during mid-day trading on Thursday, hitting $5.23. 973,186 shares of the company’s stock traded hands, compared to its average volume of 956,027. The company has a 50 day moving average of $5.62. Strata Critical Medical has a fifty-two week low of $3.67 and a fifty-two week high of $6.50. The stock has a market capitalization of $452.54 million, a PE ratio of -65.38 and a beta of 2.22.

Strata Critical Medical (NASDAQ:SRTA) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.07. The firm had revenue of $67.38 million during the quarter. Strata Critical Medical had a net margin of 20.56% and a negative return on equity of 4.06%. Equities research analysts forecast that Strata Critical Medical will post -0.14 EPS for the current year.

About Strata Critical Medical

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.